MaxCyte Analyst Ratings
BenzingaApr 23 23:21
MaxCyte Analyst Ratings
BenzingaMar 13 20:01
Analysts Offer Insights on Healthcare Companies: MaxCyte (GB:MXCT), Kura Oncology (KURA) and InMode (INMD)
TipRanksJan 23 17:09
Craig-Hallum Initiates Coverage On MaxCyte With Buy Rating, Announces Price Target of $7
BenzingaNov 30, 2023 00:10
MaxCyte Analyst Ratings
BenzingaNov 30, 2023 00:08
MaxCyte Analyst Ratings
BenzingaOct 5, 2023 20:28
Stephens & Co. Reiterates Overweight on MaxCyte, Maintains $12 Price Target
BenzingaMar 28, 2023 19:25
No Data
No Data